Auf geht's
ABBVIE INC. DL-,01ABBVIE INC. DL-,01ABBVIE INC. DL-,01

ABBVIE INC. DL-,01

Keine Trades
Auf Super-Charts wechseln
Übersicht Finanzdaten Nachrichten Ideen Diskussionen Technische Daten Prognose
Anleihen

4AB Anleihen

Unten befindet sich eine Liste von ABBVIE INC. DL-,01 Unternehmensanleihen. Investoren entscheiden sich oft für Unternehmensanleihen, weil sie eine gesteigerte Stabilität zu Zeiten von erheblichen Marktvolatilitäten bieten. Sehen Sie sich die Preise, Renditen und weitere Daten an. Entdecken Sie eine zuverlässige Investition.
Symbol
YTM %
Preis %
Coupon %
Verfallsdatum
Ausstehend
Nennwert
Min. Anlagebetrag
Emittent
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,72%76,50%4,63%2042-10-0167,493 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,63%78,76%4,85%2044-06-1565,232 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,27%81,10%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,71%90,67%4,55%2035-03-15107,646 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,22%90,84%3,20%2029-11-2162,515 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,14%107,16%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,01%106,63%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
4,97%98,56%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
4,94%93,14%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
4,91%97,82%4,75%2045-03-15827,091 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
4,90%99,30%4,85%2044-06-151,008 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
4,90%89,88%4,25%2049-11-215,745 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
4,89%96,70%4,63%2042-10-01389,217 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
4,89%106,11%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
4,87%97,69%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
4,83%94,52%4,40%2042-11-062,599 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4,67%93,02%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,65%96,53%2,95%2026-11-219,245 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,63%99,19%3,80%2025-03-15130,225 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
US287YAV1ABBVIE 16/36
4,59%97,33%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,49%100,47%4,55%2035-03-151,681 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4,46%100,34%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,41%105,04%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,23%99,39%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,18%99,63%3,80%2025-03-152,889 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,18%100,28%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,08%104,94%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,05%96,02%3,20%2029-11-215,437 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,03%98,70%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,01%103,24%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,89%98,06%2,95%2026-11-213,991 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,88%102,15%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3,78%92,90%2,13%2029-06-0136,462 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
3,66%96,02%2,63%2028-11-1572,107 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,08%121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,04%126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
3,04%99,57%2,60%2024-11-213,739 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,97%128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,90%89,35%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,71%99,65%2,63%2028-11-15427,793 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,68%97,57%2,13%2029-06-01506,088 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,66%97,88%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,65%94,28%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,04%123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%102,15%3,80%2025-03-151,268 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%106,34%2,60%2024-11-2110,86 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
——3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
——4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.